Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Collagen type IV alpha 3 chain (COL4A3) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory sequence that controls the stability and translation of the COL4A3 transcript (UniProt Q01955). This region contains specific binding sites for microRNAs, most notably miR-21, which act to post-transcriptionally downregulate the expression of the alpha 3 chain of type IV collagen (Gomez et al., 2015, JCI). This collagen chain is an essential structural component of the glomerular basement membrane (GBM) in the kidney. In diseases such as Alport syndrome and various forms of chronic kidney disease, the pathological overexpression of miR-21 leads to excessive repression of COL4A3 via its 3'-UTR, contributing to basement membrane thinning, fibrosis, and progressive renal failure (Noone et al., 2013, Pediatric Nephrology). Therapeutic interventions, such as the anti-miR Lademirsen (RG-012), target this regulatory axis by preventing miR-21 from binding to the COL4A3 3'-UTR, thereby restoring or stabilizing collagen production (Regulus Therapeutics, 2023). Modulating this region represents a precision medicine approach to treating genetic and fibrotic nephropathies by maintaining renal structural integrity.
Inhibition of microRNA-mediated repression via competitive binding or antisense modulation
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen type IV alpha 3 chain mRNA 3'-untranslated region (COL4A3 mRNA 3'-UTR).